Company Overview and News

 
Endeavour Appoints Vice President, Operations

11h globenewswire
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR) announces, effective today, the appointment of Nicholas (Nick) Shakesby as the new Vice President, Operations to oversee the Company’s underground mining operations in Mexico. Mr. Shakesby will report to Endeavour President and Chief Operating Officer, Godfrey Walton.
NCMGF NCM EXK NCMGY MMEX EDR

 
ASX falls further as tech, healthcare weighs

2018-10-09 theage.com.au
The Australian sharemarket slumped to another loss on Tuesday, as concerns over the US-China trade war and rising bond yields impacted healthcare and technology stocks.
SHL SKHHY NCMGF NCM NHYKF AJD NHYDY WTCHF SKHCY RSG SKHCF NCMGY RMGGY RMGGF NHY

 
ASX falls further as tech, healthcare weighs

2018-10-09 watoday.com.au
The Australian sharemarket slumped to another loss on Tuesday, as concerns over the US-China trade war and rising bond yields impacted healthcare and technology stocks.
SHL SKHHY NCMGF NCM NHYKF AJD NHYDY WTCHF SKHCY RSG SKHCF NCMGY RMGGY RMGGF NHY

 
ASX falls further as tech, healthcare weighs

2018-10-09 smh.com.au
The Australian sharemarket slumped to another loss on Tuesday, as concerns over the US-China trade war and rising bond yields impacted healthcare and technology stocks.
SHL SKHHY NCMGF NCM NHYKF AJD NHYDY WTCHF SKHCY RSG SKHCF NCMGY RMGGY RMGGF NHY

2
Banks weigh on ASX on credit crunch fears

2018-10-05 theage.com.au
Three positive trading sessions in the back half of the week were not enough to wipe a poor start to the week for the Australian sharemarket, which closed the week lower.
NCMGF WOPEF NCM RIO BLT RIO AWCMF SCEXF OGFGY AWCMY RTPPF RTNTF SBM MS BHPBF WPL WOPEY NCMGY BHP RIO BBL BHP OGFGF BHPLF ORG SAR

2
Banks weigh on ASX on credit crunch fears

2018-10-05 watoday.com.au
Three positive trading sessions in the back half of the week were not enough to wipe a poor start to the week for the Australian sharemarket, which closed the week lower.
NCMGF WOPEF NCM RIO BLT RIO AWCMF SCEXF OGFGY AWCMY RTPPF RTNTF SBM MS BHPBF WPL WOPEY NCMGY BHP RIO BBL BHP OGFGF BHPLF ORG SAR

2
Banks weigh on ASX on credit crunch fears

2018-10-05 smh.com.au
Three positive trading sessions in the back half of the week were not enough to wipe a poor start to the week for the Australian sharemarket, which closed the week lower.
NCMGF WOPEF NCM RIO BLT RIO AWCMF SCEXF OGFGY AWCMY RTPPF RTNTF SBM MS BHPBF WPL WOPEY NCMGY BHP RIO BBL BHP OGFGF BHPLF ORG SAR

 
Alumina miners lead ASX higher

2018-10-04 theage.com.au
Australian shares advanced for a second consecutive session, led by local alumina exposed stocks as the world's largest refinery shut down production indefinitely.
NCMGF WOPEF NCM BLT AWCMF EVN TCL NST OGFGY SYDDF AWCMY SYD SBM GMG CAHPF BHPBF MFG WPL TRAUF WOPEY NESRF NCMGY BHP BBL BHP NHRNY OGFGF BHPLF ORG

 
Alumina miners lead ASX higher

2018-10-04 watoday.com.au
Australian shares advanced for a second consecutive session, led by local alumina exposed stocks as the world's largest refinery shut down production indefinitely.
NCMGF WOPEF NCM BLT AWCMF EVN TCL NST OGFGY SYDDF AWCMY SYD SBM GMG CAHPF BHPBF MFG WPL TRAUF WOPEY NESRF NCMGY BHP BBL BHP NHRNY OGFGF BHPLF ORG

 
Alumina miners lead ASX higher

2018-10-04 smh.com.au
Australian shares advanced for a second consecutive session, led by local alumina exposed stocks as the world's largest refinery shut down production indefinitely.
NCMGF WOPEF NCM BLT AWCMF EVN TCL NST OGFGY SYDDF AWCMY SYD SBM GMG CAHPF BHPBF MFG WPL TRAUF WOPEY NESRF NCMGY BHP BBL BHP NHRNY OGFGF BHPLF ORG

 
Ausmex Mining Group’s Burra project holds potential for world-class IOCG deposit according to AusLAMP study

2018-10-04 proactiveinvestors.com.au
Ausmex Mining Group Ltd (ASX:AMG) has had the magnetotelluric (MT) anomaly beneath its Burra project area in South Australia validated by independent expert Professor Kenneth Collerson.
NCMGF NCM NCMGY

2
ASX closes higher on gold miners

2018-10-03 theage.com.au
Australian shares closed the session higher, ending a poor start to the week's trading, as the major material stocks led the market gains.
NCMGF NCM RIO BLT RIO EVN SCEXF NST IGO RSG RTPPF RMGGF RTNTF IOOFY SBM CAHPF FMG MS BHPBF IFL IIDDY FSUGY NESRF IOOFF NCMGY FSUMF RMGGY BHP RIO BBL BHP NHRNY BHPLF SAR

2
ASX closes higher on gold miners

2018-10-03 watoday.com.au
Australian shares closed the session higher, ending a poor start to the week's trading, as the major material stocks led the market gains.
NCMGF NCM RIO BLT RIO EVN SCEXF NST IGO RSG RTPPF RMGGF RTNTF IOOFY SBM CAHPF FMG MS BHPBF IFL IIDDY FSUGY NESRF IOOFF NCMGY FSUMF RMGGY BHP RIO BBL BHP NHRNY BHPLF SAR

2
ASX closes higher on gold miners

2018-10-03 smh.com.au
Australian shares closed the session higher, ending a poor start to the week's trading, as the major material stocks led the market gains.
NCMGF NCM RIO BLT RIO EVN SCEXF NST IGO RSG RTPPF RMGGF RTNTF IOOFY SBM CAHPF FMG MS BHPBF IFL IIDDY FSUGY NESRF IOOFF NCMGY FSUMF RMGGY BHP RIO BBL BHP NHRNY BHPLF SAR

 
Tectonic Gold drilling now, results expected to validate decade-long research program

2018-09-27 proactiveinvestors.com.au
Tectonic Gold Plc (NEX:TTAU) CEO Brett Boynton introduces Proactive Investors to the gold exploration company, which recently listed on the NEX Exchange Growth Market.
NCMGF NCM NCMGY EVN CAHPF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:NCM / NEWCREST MINING LIMITED on message board site Silicon Investor.

FNCM Finet.Com FNCM Finet.Com FNCM Finet.Com General Communication, Inc. GNCMA General Communication, Inc. GNCMA General Communication, Inc. GNCMA
FNCM FNCM FNCM BNCM - mortgage lending over internet BNCM - mortgage lending over internet BNCM - mortgage lending over internet
General Communications Cl A (GNCMA) General Communications Cl A (GNCMA) General Communications Cl A (GNCMA)